Generate a tailored SOP for Dr. Przemyslaw Sapieha. Improve your application with a focused, well-structured draft.
Mike Sapieha is a distinguished researcher in the field of retinal cell biology, focusing on the aging of the central nervous system and the development of therapies for major causes of blindness. He completed his bachelor’s degree in biochemistry at McGill University, followed by two postdoctoral fellowships, one at McGill and another at Harvard Medical School. Mike established a vision health team at the Maisonneuve-Rosemont Hospital Research Center and has shifted his research focus from gene therapy to understanding the impact of neuronal metabolism on ocular blood vessels. He is the founder and Chief Scientific Officer of SemaThera Inc. in Montreal and has served as Chief Scientist at UNITY Biotechnology in San Francisco. His work has garnered recognition, including the prestigious Canada Research Chair in Retinal Cell Biology, ensuring his contribution to advancing knowledge in ocular diseases.
Most programs require French B2 level; specific departments may require C1 or C2.